SynAct Pharma AB Capital Reinvestment Ratio
Latest as of June 2019:
0.22x
SynAct Pharma AB capital reinvestment ratio. SynAct Pharma AB (SYNACT) has a Capital Reinvestment Ratio of 0.22x as of June 2019, meaning it reinvests 0% of its operating cash flow (Skr1.77 Million) in capital expenditures (Skr394.90K). Check cash flow reinvestment rate of SynAct Pharma AB to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
0.22x
Capex / Operating Cash Flow
Operating Cash Flow
Skr1.77 Million
SEK
Capital Expenditures
Skr394.90K
SEK
Data as of
Jun 2019
Most recent filing
SynAct Pharma AB Capital Reinvestment Ratio by Year (None–None)
SynAct Pharma AB capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see SynAct Pharma AB (SYNACT) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow